Virtual Lecture
To receive continuing education (CE) credit, you must complete the virtual lecture, CE posttest and activity evaluation.
1.25 CE Credits Available Until: December 30, 2020
Target Audience
Nurse practitioners, nurses and oncology social workers at the intermediate and advanced levels involved in the care of patients with chronic myeloid leukemia (CML).
Learning Objectives
At the conclusion of this program, participants will be able to:
- Describe the symptoms and treatment of Chronic Myeloid Leukemia (CML)
- Identify tests used to diagnose disease and monitor treatment of CML
- Explain the overarching goals of treatment for the types of CML
- Explain approved and emerging treatment options for CML, including stem cell transplantation, and the role of clinical trials
- Describe strategies to manage treatment side effects as well as potential long-term and late effects of treatments for CML
Faculty
Jorge Cortes, MD
Chief, CML and AML Sections
Department of Leukemia
The University of Texas MD Anderson Cancer Center
Houston, TX
Elizabeth S. Kaled, RN-BS, MS, NP-C, FNP-BC
Advanced Practice Nurse
Department of Leukemia
The University of Texas MD Anderson Cancer Center
Houston, TX
Deborah McCue, PharmD, BCOP
Manager, Clinical Pharmacy Services
Division of Pharmacy
The University of Texas MD Anderson Cancer Center
Houston, TX
Gail Sperling, MPH, CHES
Senior Manager
Information Resource Center
The Leukemia & Lymphoma Society
Rye Brook, NY
Providers
This activity is provided by The Leukemia & Lymphoma Society.
< Back to Continuing Education